Cancer type | Gene | β (coef) | HR | 95% CI | P value |
---|---|---|---|---|---|
COAD | ANKZF1 | 0.543 | 1.722 | 0.972–3.049 | 0.062 |
 | STC2 | 0.257 | 1.293 | 1.030–1.624 | 0.027 |
 | SUCLG2P2 |  − 2.124 | 0.120 | 0.035–0.407 | 0.001 |
 | P4HA1 | 0.359 | 1.432 | 1.013–2.025 | 0.042 |
 | GPC1 | 0.326 | 1.385 | 1.040–1.843 | 0.026 |
 | PCK1 |  − 0.256 | 0.774 | 0.632–0.950 | 0.014 |
 | \({\text{Risk}}\;{\text{model}}\;{\text{formula}} = \mathop \sum \nolimits_{i = 1}^{n} {\text{expression }}\;{\text{of }}Gi \times \beta i\) = expression of ANKZF1 × 0.543 + expression of STC2 × (0.257) + expression of SUCLG2P2 × (− 2.124) + expression of P4HA1 × (0.359) + expression of GPC1 × (0.326) + expression of PCK1 × (− 0.256) |
Cancer type | Gene | β (coef) | HR | 95% CI | P value |
---|---|---|---|---|---|
READ | TSTA3 | 0.752 | 2.121 | 1.067–4.218 | 0.032 |
 | PKP2 |  − 0.725 | 0.484 | 0.274–0.856 | 0.013 |
 | \(\mathop {{\text{Risk}}\;{\text{model}}\;{\text{formula}} = \sum }\nolimits_{i = 1}^{n} {\text{expression}}\;{\text{of}}\;Gi \times \beta i\) = expression of TSTA3 × 0.752 + expression of PKP2 × (− 0.725) |